Results 91 to 100 of about 10,413 (156)

Prognostic Factors in Oropharyngeal Cancer Treated With Definitive Chemoradiotherapy

Cancer Medicine, Volume 15, Issue 5, May 2026.
We studied 630 OPSCC patients treated with chemoradiotherapy in our institute. There was a low incidence of HPV‐associated OPSCC in our cohort. Tobacco remains the main etiological factor in our cohort. HPV status by p16 IHC, T stage, RT technique, and RT doses were independent prognostic factors for OPSCC patients.
Sheetal R. Kashid, Ashwini Budrukkar, Monali Swain, Sarbani Ghosh Laskar, Vedang Murthy, Tejpal Gupta, Ajay Sasidharan, Vijay Patil, Amit Joshi, Vanita Noronha, Neha Mittal, Manoj Mahimkar, Asawari Patil, Usha Patel, Shwetabh Sinha, Anuj Kumar, Nandini Menon, Munita Bal, Kumar Prabhash, Jai Prakash Agarwal   +19 more
wiley   +1 more source

Clinical Significance of Biomarkers in Oropharyngeal Squamous Cell Carcinoma: Recurrence Prediction and Treatment Response

Cancer Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background Oropharyngeal squamous cell carcinoma (OPSCC) accounts for a substantial proportion of head and neck cancers, with a rising incidence largely driven by human papillomavirus (HPV) infection. Despite advances in multimodal treatment, disease recurrence remains common and limits long‐term survival, highlighting the need for reliable ...
Yunxia Chen, Wenyu Zhang, Xiang Gao, Kongling Xing, Yijing Ren, Jinyu Hu, Zhihao Xie, Ping Zhou   +7 more
wiley   +1 more source

Resveratrol for Cancer Radio‐Sensitization: Ready for Prime Time or Future Perspective

Food Science &Nutrition, Volume 14, Issue 5, May 2026.
Resveratrol exerts antioxidant and anti‐inflammatory effects by reducing reactive oxygen species and suppressing NF‐κB and JAK/STAT signaling pathways. It modulates metabolic signaling through AMPK‐dependent inhibition of mTOR, influencing cell survival and inflammatory responses.
Maryam Fallah, Ali Soleimani, Ali Nouri, Melika Fallah, Alireza Haghighi, Ahmad Reza Dehpour, Abolfazl Zendehdel, Soraiya Ebrahimpour‐Koujan   +7 more
wiley   +1 more source

Intratumoral Microorganisms in Tumors: Current Understanding and Emerging Therapeutic Strategies

MedComm, Volume 7, Issue 5, May 2026.
Tumors are no longer viewed as sterile but dynamic ecosystems harboring low‐biomass intratumoral microbiota. These microbes, derived from gut, oral cavity, or circulation, shape tumorigenesis and therapy response via core mechanisms: immunomodulation (regulating T cells, macrophages), metabolic reprogramming (SCFAs, indoles, bile acids), chronic ...
Haoling Zhang, Zengkan Du, Ping Lu, Aimin Jiang, Yadong Guo, Yawei Liu, Zhijing Song, Bing Dai, Wangzheqi Zhang   +8 more
wiley   +1 more source

Radiosensitive Adamantinoma [PDF]

BMJ, 1963
openaire   +2 more sources

Targeting Tumor Stroma: Current Challenges and Future Directions

MedComm, Volume 7, Issue 5, May 2026.
Figure 1. Mechanism of ECM reprogramming. Cancer‐associated fibroblasts (CAFs), cancer‐associated macrophages (CAMs), and other mesenchymal cells alter the ECM composition and increase its stiffness by depositing matrix components such as collagen and hyaluronic acid, and secreting cross‐linking agents like lysyl oxidase homolog 2 (LOXL2).
Siwei Wang, Haofan Hu, Weifeng Zeng, Lu Qin, Xiaoping Chen, Zhibin Liao, Furong Liu, Zhanguo Zhang   +7 more
wiley   +1 more source

Acute radiation unjury of mice and the influence of sudden time shift [PDF]

, 1984
Arbogast, B., Gerbes, Alexander L., Messerschmidt, O., Schick, P.   +3 more
core   +1 more source

Radiosensitizer

RADIOISOTOPES, 1981
openaire   +2 more sources

Radiosensitization

, 2018
Weber, K. J., Witte, S., Rothkamm, K., Rave-Fraenk, Margret, Virsik-Koepp, Patricia, Kupper, J. H., Rudat, V., Lobrich, M.   +7 more
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Modifiers of radiosensitivity

Experientia, 1989
Many different methods exist by which the radiosensitivity of cells, and hence of normal tissues and tumours, can be manipulated. Several of these can be traced to a common redox pathway involving competition between oxidising and reducing species. Others involve the biochemical enzyme systems required for removal of DNA lesions.
A, Rojas, J, Denekamp
openaire   +2 more sources